Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (12907)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Nov 12, 2017 (publication date) through Dec 28, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Virology
ISSN
2220-3249
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Bichoupan K, Tandon N, Crismale JF, Hartman J, Del Bello D, Patel N, Chekuri S, Harty A, Ng M, Sigel KM, Bansal MB, Grewal P, Chang CY, Leong J, Im GY, Liu LU, Odin JA, Bach N, Friedman SL, Schiano TD, Perumalswami PV, Dieterich DT, Branch AD. Real-world cure rates for hepatitis C virus treatments that include simeprevir and/or sofosbuvir are comparable to clinical trial results. World J Virol 2017; 6(4): 59-72 [PMID: 29147645 DOI: 10.5501/wjv.v6.i4.59] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3249/full/v6/i4/59.htm |
| Number | Citing Articles |
| 1 |
Eiji Mita, Lauren J. Liu, Danielle Shing, Lindsey Force, Kouji Aoki, Daisuke Nakamoto, Akinobu Ishizaki, Hiroki Konishi, Hajime Mizutani, Leslie J. Ng. Real-world Safety and Effectiveness of 24-week Sofosbuvir and Ribavirin Treatment in Patients Infected with Rare Chronic Hepatitis C Virus Genotypes 3, 4, 5, or 6 in Japan. Internal Medicine 2023; 62(10): 1405 doi: 10.2169/internalmedicine.0067-22
|
| 2 |
Zyad Hussein J. AL-Qaisi, Alaa Hussein J. AL-Qaisi, Wessal M. Khamis, Zaman Ahmed Hussein, Iman Rajab Mohammed. The transmission risk factors of hepatitis B and C infection in dental treating and tattooing among hemodialysis patients. Research Journal of Pharmacy and Technology 2023; : 418 doi: 10.52711/0974-360X.2023.00071
|
| 3 |
Michael E. Porter, Thomas H. Lee, Alice C. A. Murray. The Value-Based Geography Model of Care. NEJM Catalyst 2020; 1(2) doi: 10.1056/CAT.19.1130
|
| 4 |
Ismaeel A Alshoaibi, Abdullah Al-Gamli, Mohammed Abdullah, Basheer Abdo, Khaled H Alzanen, Mohammed Alhakamy, Mamoon Al-Namer, Faisal Ahmed, Munther Tamesh , Wadhah Mahdi , Zeyad Abdo, Marwa Mohammed . Effectiveness of Ledipasvir-Sofosbuvir 12 Weeks After Hepatitis C Virus Genotype 1 Infection and the Factors Associated With Sustained Virologic Response: A Retrospective Study. Cureus 2024; doi: 10.7759/cureus.68249
|
| 5 |
Imran Shahid, Qaiser Jabeen. Hepatitis C Virus-Host Interactions and Therapeutics: Current Insights and Future Perspectives. 2023; : 231 doi: 10.2174/9789815123432123010012
|